Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LabCentral
Biotech
Sanofi pays $160M for mRNA tech to reprogram T cells in vivo
The platform could enable patients to make their own CAR-T cells, eliminating the complex cell therapy supply chain while improving safety and dosing.
Nick Paul Taylor
Apr 12, 2021 7:45am
LabCentral entrepreneurs volunteer for COVID-19 diagnostic trial
Nov 2, 2020 9:25am
Astellas to support new LabCentral biomanufacturing incubator
Oct 4, 2019 10:40am
ALS-focused QurAlis raises $5.5M, heads to LabCentral’s JLABS
Nov 19, 2018 8:00am